Hide metadata

Cost-Utility Analysis of Pirfenidone in combination with Best Supported Care vs. Best Supported Care for patients with Idiopathic Pulmonary Fibrosis in Norway.

dc.contributor.authorWestermann, Lutz-Vincent
dc.date.accessioned2020-01-28T23:45:42Z
dc.date.issued2019
dc.identifier.citationWestermann, Lutz-Vincent. Cost-Utility Analysis of Pirfenidone in combination with Best Supported Care vs. Best Supported Care for patients with Idiopathic Pulmonary Fibrosis in Norway.. Master thesis, University of Oslo, 2019
dc.identifier.urihttp://hdl.handle.net/10852/72585
dc.description.abstracteng
dc.language.isoeng
dc.subjectrare disease
dc.subjectsurvival analysis
dc.subjectmarkov model
dc.subjectCost-Utility Analysis
dc.subjectCost-Effectiveness Analysis
dc.subjectmodelling
dc.subjectIPF
dc.titleCost-Utility Analysis of Pirfenidone in combination with Best Supported Care vs. Best Supported Care for patients with Idiopathic Pulmonary Fibrosis in Norway.eng
dc.typeMaster thesis
dc.date.updated2020-01-28T23:45:42Z
dc.creator.authorWestermann, Lutz-Vincent
dc.date.embargoenddate3019-06-29
dc.rights.termsDette dokumentet er ikke elektronisk tilgjengelig etter ønske fra forfatter. Tilgangskode/Access code A
dc.identifier.urnURN:NBN:no-75714
dc.type.documentMasteroppgave
dc.rights.accessrightsclosedaccess
dc.identifier.fulltextFulltext https://www.duo.uio.no/bitstream/handle/10852/72585/1/Master-Thesis---CUA---Lutz-Vincent-Westermann_2019.pdf


Files in this item

Name:
Master-Thesis---CUA---Lutz-Vin ...
Size:
5.407Mb
Format:
application/
View/Open

Appears in the following Collection

Hide metadata